Unknown

Dataset Information

0

Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.


ABSTRACT: Oncolytic viruses that selectively lyse tumor cells with minimal damage to normal cells are a new area of therapeutic development in oncology. An attenuated herpesvirus encoding the granulocyte-macrophage colony stimulating factor (GM-CSF), known as talimogene laherparepvec (T-VEC), has been identified as an attractive oncolytic virus for cancer therapy based on preclinical tumor studies and results from early-phase clinical trials and a large randomized Phase III study in melanoma. In this review, we discuss the basic biology of T-VEC, describe the role of GM-CSF as an immune adjuvant, summarize the preclinical data, and report the outcomes of published clinical trials using T-VEC. The emerging data suggest that T-VEC is a safe and potentially effective antitumor therapy in malignant melanoma and represents the first oncolytic virus to demonstrate therapeutic activity against human cancer in a randomized, controlled Phase III study.

SUBMITTER: Hughes T 

PROVIDER: S-EPMC4918360 | biostudies-other | 2014

REPOSITORIES: biostudies-other

altmetric image

Publications

Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma.

Hughes Tasha T   Coffin Robert S RS   Lilley Caroline E CE   Ponce Rafael R   Kaufman Howard L HL  

Oncolytic virotherapy 20140115


Oncolytic viruses that selectively lyse tumor cells with minimal damage to normal cells are a new area of therapeutic development in oncology. An attenuated herpesvirus encoding the granulocyte-macrophage colony stimulating factor (GM-CSF), known as talimogene laherparepvec (T-VEC), has been identified as an attractive oncolytic virus for cancer therapy based on preclinical tumor studies and results from early-phase clinical trials and a large randomized Phase III study in melanoma. In this revi  ...[more]

Similar Datasets

| S-EPMC3719441 | biostudies-literature
| S-EPMC4995227 | biostudies-literature
| S-EPMC2920049 | biostudies-literature
| S-EPMC10127946 | biostudies-literature
| S-EPMC5916331 | biostudies-literature
| S-EPMC3852053 | biostudies-literature
| S-EPMC3707315 | biostudies-literature
| S-EPMC5926922 | biostudies-literature
| S-EPMC404575 | biostudies-literature